AbCellera Biologics Inc. (ABCL) Business Metric Overview - Stocknear

AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.22
0.06 (1.44%)
At close: Sep 05, 2025, 3:59 PM
4.23
0.24%
After-hours: Sep 05, 2025, 04:11 PM EDT

AbCellera Biologics Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
License Revenue 10.45M 167K 651K 218K 370K 180K 185K 186K 226K 372K 165K 154K 147K 231K 86K 190K 263K 20.26M
License Revenue Growth +6154.49% -74.35% +198.62% -41.08% +105.56% -2.70% -0.54% -17.70% -39.25% +125.45% +7.14% +4.76% -36.36% +168.60% -54.74% -27.76% -98.70% n/a
Research Fees Revenue 6.64M 4.07M 10.22M 6.29M 5.45M 9.77M 8.74M 6.41M 9.83M 10.57M 11.42M 7.51M 12.54M 9.33M 4.75M 5.13M 5.21M 3.99M
Research Fees Revenue Growth +63.20% -60.20% +62.52% +15.33% -44.21% +11.79% +36.33% -34.76% -7.00% -7.48% +52.16% -40.12% +34.34% +96.65% -7.45% -1.67% +30.83% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 21.99M 19.07M 19.16M 22.28M 23.33M 20.72M 19.07M 17.84M 19.36M 18.91M 15.71M 16.88M 17.53M 16.64M 14.72M 12.49M 12.5M 9M 8.03M 3.59M 2.04M 2.09M 1.45M 994.36K 785.79K 785.79K
Selling, General, and Administrative Revenue Growth +15.30% -0.50% -13.99% -4.48% +12.60% +8.61% +6.94% -7.88% +2.42% +20.37% -6.96% -3.71% +5.37% +13.05% +17.85% -0.08% +38.87% +12.13% +123.32% +75.75% -2.01% +44.37% +45.38% +26.54% 0.00% n/a
Research and Development Revenue 39.21M 42.5M 46.08M 40.97M 40.93M 39.29M 48.62M 37.92M 36.47M 52.65M 28.25M 26.58M 26.68M 26.37M 17.21M 17.45M 15.05M 12.35M 8.64M 7.5M 9.14M 4.12M 3.31M 2.78M 2.01M 2.01M
Research and Development Revenue Growth -7.73% -7.77% +12.47% +0.10% +4.17% -19.20% +28.23% +3.96% -30.72% +86.39% +6.26% -0.39% +1.21% +53.21% -1.38% +15.98% +21.81% +43.02% +15.23% -18.03% +122.05% +24.46% +18.93% +38.33% 0.00% n/a
Sales and Marketing Revenue 3.01M 2.84M 3.14M 3.13M 3.14M 3.37M 3.1M 3.47M 3.84M 3.77M 2.69M 3.09M 3.12M 2.37M 1.83M 1.22M 1.29M 2.58M 2.23M 626K 547K 437K 470.57K 291.42K 250.33K 250.33K
Sales and Marketing Revenue Growth +5.88% -9.61% +0.29% -0.03% -6.81% +8.55% -10.61% -9.71% +1.86% +40.13% -12.88% -0.99% +31.65% +29.72% +50.12% -6.02% -49.77% +15.51% +256.54% +14.44% +25.17% -7.13% +61.47% +16.42% 0.00% n/a